Application 761080

Type
BLA
Sponsor
HOSPIRA INC

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761080Nivestymfilgrastim-aafi351(k) BiosimilarRx2026-06-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NIVESTYMFILGRASTIM-AAFIVIAL;SINGLE-DOSE300MCG/MLNoNo
002NIVESTYMFILGRASTIM-AAFIVIAL;SINGLE-DOSE480MCG/1.6MLNoNo
003NIVESTYMFILGRASTIM-AAFIINJECTABLE;INJECTION300MCG/0.5MLNoNo
004NIVESTYMFILGRASTIM-AAFIINJECTABLE;INJECTION480MCG/0.8MLNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NivestymFILGRASTIM-AAFIPfizer Laboratories Div Pfizer Incd23ab39c-b6ec-41cf-a529-9dd2852c9d9a2025-08-12Warnings, Adverse reactionsExact identifier
application number: BLA761080
ndc (product): 0069-0293
ndc (product): 0069-0291
ndc (product): 0069-0294
ndc (product): 0069-0292

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 36 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0069-0291Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0291Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0291Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0291Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0291Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0291Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0291Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0291Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0291Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0292Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0292Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0292Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0292Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0292Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0292Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0292Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0292Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0292Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0293Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0293Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0293Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0293Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0293Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0293Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0293Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0293Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0293Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0294Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0294Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0294Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0294Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0294Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0294Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0294Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0294Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent
0069-0294Nivestymfilgrastim-aafiPfizer Laboratories Div Pfizer IncBLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77584SUPPL 2024-02-20
77583SUPPL 2024-02-20
75317SUPPL 2023-08-29
75315SUPPL 2023-08-28
67439SUPPL2021-05-07
67397SUPPL2021-05-04
57738ORIG2019-02-21
54949ORIG2018-07-23
54938ORIG2018-07-20
63002ORIG1900-01-01
63001ORIG1900-01-01
63000ORIG1900-01-01
62999ORIG1900-01-01